Aemetis Inc. buy krebskrebs
Start price
25.01.21
/
50%
€4.10
Target price
25.01.22
€4.50
Performance (%)
101.22%
End price
26.01.22
€8.25
Summary
This prediction ended on 26.01.22 with a price of €8.25. The BUY prediction by krebskrebs for Aemetis Inc. saw massive gains of 101.22%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aemetis Inc. | -4.074% | -4.074% | -56.394% | -68.232% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by krebskrebs for this prediction
In the thread Aemetis Inc. diskutieren
In the thread Trading Aemetis Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten